Five Data Security Essentials in SaaS for GxP Environments
When implementing Software as a Service (SaaS) solutions in Good Practices (GxP) regulated environments, data security and especially integrity are …
When implementing Software as a Service (SaaS) solutions in Good Practices (GxP) regulated environments, data security and especially integrity are …
Dr Paul Lohmann® has the world’s largest portfolio of mineral salts for use as active pharmaceutical ingredients (APIs). For the …
The famous chemist Justus von Liebig said: “Salt is the most precious of all jewels which the earth gives us.” …
Maintaining strict standards of cleanliness and safety is crucial in cleanroom environments. Here, we discuss the importance of cleanroom apparel …
Dry granulation, also known as roller compaction, has become a widely used granulation technology in recent years. It has a …
Tablets are the most important oral dosage form in the pharmaceutical industry. The advantages of tablets are numerous. First and foremost …
Rapid development and the best results right from the start are the goals of research and development departments in the …
Through our science-led approach and extensive experience in product development, Upperton can support you with aseptic and terminally sterilised small …
Drug products containing active biological ingredients form one of the most important and fastest growing sectors of the pharmaceutical industry. The …
As a leading contract development and manufacturing organisation, Upperton's defining traits lie in our adaptability and nimbleness, enabling rapid product …
The nasal route offers a number of benefits over some of the traditional routes of administration for biologics. This includes rapid …
The pharmaceutical industry is thought to be the world’s biggest polluter, with latest research concluding that it is less climate …
Large-molecule drug products in solution may be susceptible to denaturing when exposed to shock, vibration, temperature and pressure, which occur …
When a monoclonal antibody therapy advances through its development lifecycle, planning ahead and optimising the biopharmaceutical cold chain is key …
Competing priorities, changing expectations, cost pressures, sustainability initiatives and emerging markets ‒ these are some of the challenges facing cold …